Effect of 8 Endurance and Combined Training on Fetuin-A, TGF-ß and Metabolic Syndrome

The Effect of 8 Weeks Endurance and Combined Training on Serum Levels of Fetuin-A, Transforming growth factor beta )TGF-ß( and Metabolic Syndrome in Overweight and Obese Women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180612040073N5

Enrollment

Registered

2019-05-06

Start date

2018-10-23

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity. Overweight and obesity

Interventions

Intervention 1: Intervention group: Endurance Exercise. Intervention 2: Intervention group: Combined exercises (Endurance and Resistance). Intervention 3: Control group: .

Eligibility

Sex/Gender

Female

Age

30 Years to 45 Years

Inclusion criteria

Inclusion criteria: Healthy People Inactive Non-Smoking Not Using Diet And Medicines To Lose Weight Body mass index greater than 25

Exclusion criteria

Exclusion criteria: Heart disease Respiratory problems Joint pains Use of Metabolic Drugs

Design outcomes

Primary

Measure	Time frame
Fetuin A Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: "Fetuin A" test kit.;Transforming growth factor beta. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: "Transforming growth factor beta" test kit.;Triglyceride. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: " Triglyceride" test kit.;Low-density lipoprotein (LDL). Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: "LDL" test kit.;High-density lipoprotein (HDL). Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: "HDL" test kit.;Cholesterol. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: " Cholesterol" test kit.;Subcutaneous fat. Timepoint: 24 hours before the intervention and 24 hours after the last session of the research protocol. Method of measurement: Using the Caliper.;Body mass index. Timepoint: 24 hours before the intervention and 24 hours after the last session of the research protocol. Method of measurement: Based on the formula "Weight divided by height squared".	—

Measure

Time frame

Fetuin A Changes. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: "Fetuin A" test kit.;Transforming growth factor beta. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. Method of measurement: "Transforming growth factor beta" test kit.;Triglyceride. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: " Triglyceride" test kit.;Low-density lipoprotein (LDL). Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: "LDL" test kit.;High-density lipoprotein (HDL). Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: "HDL" test kit.;Cholesterol. Timepoint: Blood sampling at the beginning of the study (24 hours before the intervention) and 24 hours after the last session of the research protocol. 12 hours in fasting mode. Method of measurement: " Cholesterol" test kit.;Subcutaneous fat. Timepoint: 24 hours before the intervention and 24 hours after the last session of the research protocol. Method of measurement: Using the Caliper.;Body mass index. Timepoint: 24 hours before the intervention and 24 hours after the last session of the research protocol. Method of measurement: Based on the formula "Weight divided by height squared".

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Vahidian-Rezazadeh

University of Sistan and Baluchestan

vahidian@ped.usb.ac.ir+98 54 3341 6107

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026